DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Byrd JC, Furman RR, Coutre SE, Burger JA, Blum KA, Coleman M. et al.
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.
Blood 2015;
125: 2497-506
We do not assume any responsibility for the contents of the web pages of other providers.